Cargando…

Bevacizumab for non-small cell lung cancer patients with brain metastasis: A meta-analysis

This study evaluates the efficacy and safety of bevacizumab (BEV) in the treatment of non-small cell lung cancer (NSCLC) patients with brain metastases (BM) by performing meta-analyses of response and survival indices. Seventeen studies were included. BEV treatment was associated with a lower new BM...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Ping, Wang, Yu-Dong, Wei, Zong-Min, Deng, Qi-Jun, Xu, Tong, Liu, Jiang, Luo, Na, Hou, Juan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	De Gruyter 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7706125/ https://www.ncbi.nlm.nih.gov/pubmed/33313410 http://dx.doi.org/10.1515/med-2020-0192

Ejemplares similares

The Efficacy and Safety of Afatinib in Non-Small Cell Lung Cancer Patients with Brain Metastasis: A Meta-Analysis
por: Jin, Hui, et al.
Publicado: (2023)

Meta-analysis of the role of bevacizumab in extensive stage small cell lung cancer
por: Zhu, Yan-Juan, et al.
Publicado: (2017)

Bevacizumab suppresses the growth of established non-small-cell lung cancer brain metastases in a hematogenous brain metastasis model
por: Masuda, Chinami, et al.
Publicado: (2019)

Intracameral bevacizumab administered for non-small cell lung cancer metastasis to iris
por: Schell, Jonathan C., et al.
Publicado: (2011)

Brain Metastasis in Patients with Small Cell Lung Cancer
por: Li, Na, et al.
Publicado: (2021)

The different overall survival between single-agent EGFR-TKI treatment and with bevacizumab in non-small cell lung cancer patients with brain metastasis
por: Chiu, Tzu-Hsuan, et al.
Publicado: (2022)

Non-small cell lung cancer with iris metastasis controlled with osimertinib and monthly intravitreal bevacizumab
por: Wong, Margaret, et al.
Publicado: (2022)

A Case Report of Intravitreal Bevacizumab for Iris Metastasis of Small Cell Lung Carcinoma with Neovascular Glaucoma
por: Hidaka, Takako, et al.
Publicado: (2018)

Clinical Experience of Bevacizumab for Radiation Necrosis in Patients with Brain Metastasis
por: Park, Moowan, et al.
Publicado: (2020)

Greater efficacy of chemotherapy plus bevacizumab compared to chemo- and targeted therapy alone on non-small cell lung cancer patients with brain metastasis
por: Tang, Ning, et al.
Publicado: (2015)

Bevacizumab for the treatment of non-small cell lung cancer patients with synchronous brain metastases
por: Ascha, Mustafa S., et al.
Publicado: (2019)

Efficacy and safety of bevacizumab plus erlotinib versus bevacizumab or erlotinib alone in the treatment of non-small-cell lung cancer: a systematic review and meta-analysis
por: Zhang, Shu, et al.
Publicado: (2016)

Bevacizumab and gefitinib enhanced whole-brain radiation therapy for brain metastases due to non-small-cell lung cancer
por: Yang, R.F., et al.
Publicado: (2017)

Potential benefit of osismertinib plus bevacizumab in leptomeningeal metastasis with EGFR mutant non-small-cell lung cancer
por: Yi, Yali, et al.
Publicado: (2022)

Efficacy of XELOX plus Bevacizumab in Brain Metastasis from Rectal Cancer
por: Yoshida, Yoichiro, et al.
Publicado: (2014)

The Effectiveness of Bevacizumab in Radionecrosis After Radiosurgery of a Single Brain Metastasis
por: Delishaj, Durim, et al.
Publicado: (2015)

Intravitreal Bevacizumab for Choroidal Metastasis of Lung Carcinoma; a Case Report
por: de la Barquera Cordero, Aída Sánchez, et al.
Publicado: (2010)

The benefit of bevacizumab therapy in patients with refractory vasogenic edema caused by brain metastasis from lung and colon cancers
por: Bai, Xuexue, et al.
Publicado: (2022)

Zebrafish xenograft model for studying mechanism and treatment of non-small cell lung cancer brain metastasis
por: Fan, Ruo-Yue, et al.
Publicado: (2021)

Correction: Potential benefit of osimertinib plus bevacizumab in leptomeningeal metastasis with EGFR mutant non-small-cell lung cancer
por: Yi, Yali, et al.
Publicado: (2022)

Osimertinib combined with bevacizumab as the first‐line treatment in non‐small cell lung cancer patients with brain metastasis harboring epidermal growth factor receptor mutations
por: Zhang, Ling, et al.
Publicado: (2023)

WDR5 is a prognostic biomarker of brain metastasis from non-small cell lung cancer
por: Li, Zheng, et al.
Publicado: (2022)

Efficacy and safety evaluations of anlotinib in patients with advanced non-small cell lung cancer treated with bevacizumab
por: Jiang, Fenge, et al.
Publicado: (2022)

Comparison of efficacy and safety of bevacizumab biosimilar and original bevacizumab in non-squamous non-small cell lung cancer: a systematic review and meta-analysis
por: Xiao, Xian, et al.
Publicado: (2022)

Osimertinib combined with bevacizumab for leptomeningeal metastasis from EGFR‐mutation non‐small cell lung cancer: A phase II single‐arm prospective clinical trial
por: Lu, Zhi‐qin, et al.
Publicado: (2020)

Efficacy and safety of bevacizumab combined with EGFR‐TKIs in advanced non‐small cell lung cancer: A meta‐analysis
por: Yang, Yifan, et al.
Publicado: (2021)

Choroidal metastasis: Radiation and bevacizumab at presentation
por: Maheshwari, Abhilasha, et al.
Publicado: (2023)

Complete Disappearance of Choroidal Metastasis from Lung Adenocarcinoma Treated with Bevacizumab and Chemotherapy
por: Kourie, Hampig Raphael, et al.
Publicado: (2015)

Erlotinib plus bevacizumab versus erlotinib alone in patients with EGFR-positive advanced non-small-cell lung cancer: a systematic review and meta-analysis of randomised controlled trials
por: Deng, Wusheng, et al.
Publicado: (2022)

Alterations of the Human Lung and Gut Microbiomes in Non-Small Cell Lung Carcinomas and Distant Metastasis
por: Lu, Hui, et al.
Publicado: (2021)

The efficacy and safety of paclitaxel and carboplatin with versus without bevacizumab in patients with non-small-cell lung cancer: a systematic review and meta-analysis
por: Han, Shiqian, et al.
Publicado: (2017)

Effective Treatment with Intravitreal Injection of Bevacizumab for Exudative Retinal Detachment Secondary to Choroidal Metastasis of Non-Small Cell Lung Carcinoma
por: Yasui, Hirotoshi, et al.
Publicado: (2015)

Connexins in Lung Cancer and Brain Metastasis
por: Luo, Kai-Jun, et al.
Publicado: (2020)

The spatial transcriptomic landscape of non-small cell lung cancer brain metastasis
por: Zhang, Qi, et al.
Publicado: (2022)

60. IDEAL TREATMENT REGIMEN FOR PATIENTS WITH ≥1 BRAIN METASTASIS FROM PRIMARY NON-SMALL-CELL LUNG CANCER – A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
por: Brar, Karanbir, et al.
Publicado: (2020)

Stereotactic radiosurgery for brain metastasis in non-small cell lung cancer
por: Won, Yong Kyun, et al.
Publicado: (2015)

Addition of Bevacizumab to Chemotherapy in Advanced Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
por: Lima, André Bacellar Costa, et al.
Publicado: (2011)

Effectiveness and safety of bevacizumab in extensive-disease small cell lung cancer: a systemic review and meta-analysis
por: He, Jiaxi, et al.
Publicado: (2021)

Tumoral cavitation in colorectal cancer patients with unresectable lung metastasis treated with bevacizumab and chemotherapy
por: Peng, Yu, et al.
Publicado: (2018)

Safety and Patient-Reported Outcomes of Atezolizumab Plus Chemotherapy With or Without Bevacizumab Versus Bevacizumab Plus Chemotherapy in Non–Small-Cell Lung Cancer
por: Reck, Martin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_68v9mgsqcmat9ndq4sedd7hn8k